Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Oscient Files for Chapter 11 Bankruptcy Protection

By Pharmaceutical Processing | July 14, 2009

WALTHAM, Mass. (AP) — Oscient Pharmaceuticals Corp. said Monday it has filed for Chapter 11 bankruptcy protection, and sold its chronic bronchitis drug Factive. Oscient and subsidiary Guardian II Acquisition Corp. filed in the U.S. Bankruptcy Court for the District of Massachusetts. The company is seeking relief from its debts while it reorganizes. Oscient agreed to sell one of its two drugs, Factive, to Cornerstone Therapeutics Inc. for $5 million, plus royalties and the value of the drug’s inventory. The company said it will consider strategic alternatives, including seeking a buyer for its only other approved drug, the cholesterol drug Antara, and other assets. Oscient said it expects its shares to be delisted from the Nasdaq on July 21. The company received a notice from the stock exchange on July 10 that it had failed to pay fees required to maintain its listing. Oscient does not plan to appeal the decision. The company’s shares closed at 18.1 cents on Monday. Oscient has cut 280 of its 305 jobs this year as part of an effort to preserve cash and reduce debt. In February, it eliminated 100 jobs, and in June, it cut its 150-person sales force and 30 other positions.

Related Articles Read More >

Great Point Partners logo.
Great Point Partners acquires majority stake in Eutecma to fuel sustainable cold chain growth
Driving success in fast-paced high-tech pharma construction projects
This is a photo of the Fujifilm Diosynth Biotechnologies plant under construction in Holly Springs, North Carolina.
Fujifilm, Regeneron ink $3B U.S. manufacturing agreement
This is the logo of Johnson & Johnson.
J&J breaks ground on $2B manufacturing facility in North Carolina
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE